Mirvie
Mirvie is developing a blood test for expectant mothers to predict pregnancy complications.
It was founded in 2018 by former Grail exec Maneesh Jain and Chan Zuckerberg Initiative president Dr. Stephen Quake.
The company is conducting clinical trials and plans to apply for approval for its liquid biopsy tests.
After experiencing complications during their own children s births, Maneesh Jain and Dr. Stephen Quake both committed the rest of their professional careers to helping other parents avoid unexpected conditions during pregnancy and, hopefully, any stay in the neonatal intensive care unit.
Together, they started Mirvie in 2018. Quake had been working at the Chan Zuckerberg Initiative under its Biohub group, a research unit funded by the Facebook CEO and his wife Priscilla Chan, where he developed noninvasive prenatal tests to detect genetic mutations.
Productboard
Productboard raised $72 million in a Series C round led by Tiger Global Management.
Index Ventures, Kleiner Perkins, Sequoia Capital, and Bessemer Venture Partners also participated.
Sequoia s Andrew Reed learned about Productboard through his portfolio companies, which were fans.
Product management startup Productboard has raised a $72 million Series C round, it announced on Thursday. This comes after it raised a $45 million Series B in January 2020.
The funding was led by Tiger Global Management with the company s previous backers, which include Silicon Valley heavyweights like Index Ventures, Kleiner Perkins, Sequoia Capital, and Bessemer Venture Partners, also taking part. The company did not disclose the new valuation, but after its last raise, it was valued at an estimated $300 million, according to Pitchbook.
This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
100plus, a startup that offers remote patient monitoring devices and software, raised $25 million in seed funding.
The round valued the company at around $150 million, a source told Insider.
CEO Ryan Howard said he wanted more control of the company after his experience raising venture capital with his previous company went poorly.
Keeping tabs on patients health at home has become a surging business during the coronavirus pandemic.
With the virus spreading, physicians needed to find ways to make sure their patients health stayed in check while limiting in-person visits. They turned to virtual consultations and digital tools that could be used at home to track blood pressure,